Literature DB >> 15040579

Cytokine-receptor pairing: accelerating discovery of cytokine function.

Don Foster1, Julia Parrish-Novak, Brian Fox, Wenfeng Xu.   

Abstract

Over the past decade, advances in both gene discovery and ligand-receptor pairing techniques have led to the recognition that systematic pairing of 'orphan' database-derived cytokines and/or cytokine receptors with their cognate partners can lead to a marked acceleration in the elucidation of biological function. The sometimes-restricted tissue distribution of the receptor, coupled with the highly specific bioactivity of the corresponding ligand, can direct investigators rapidly towards regulatory function and site-of-action studies. The power of cytokine-receptor pairing to accelerate the understanding of function will be illustrated, citing several examples of candidate drug discoveries. Several of these discoveries, resulting from cytokine-receptor pairings, are at present advancing towards human clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15040579     DOI: 10.1038/nrd1305

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


  11 in total

Review 1.  Endocrine control of mucosal immunity in the female reproductive tract: impact of environmental disruptors.

Authors:  B Dunbar; M Patel; J Fahey; C Wira
Journal:  Mol Cell Endocrinol       Date:  2012-01-25       Impact factor: 4.102

Review 2.  TWEAK as a target for therapy in systemic lupus erythematosus.

Authors:  Rui-Xue Leng; Hai-Feng Pan; Wei-Zi Qin; Chao Wang; Li-Li Chen; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-04-01       Impact factor: 2.316

3.  Efficient production of CYTL1 protein using mouse IgGκ signal peptide in the CHO cell expression system.

Authors:  Xiaolin Wang; Huihui Liu; Wanqiong Yuan; Yingying Cheng; Wenling Han
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-02-27       Impact factor: 3.848

4.  Preparation and characterization of monoclonal antibodies against VSTM1.

Authors:  Ting Li; Wenyan Wang; Yingyu Chen; Wenling Han
Journal:  Monoclon Antib Immunodiagn Immunother       Date:  2013-08

Review 5.  TNF superfamily: a growing saga of kidney injury modulators.

Authors:  Maria D Sanchez-Niño; Alberto Benito-Martin; Sara Gonçalves; Ana B Sanz; Alvaro C Ucero; Maria C Izquierdo; Adrian M Ramos; Sergio Berzal; Rafael Selgas; Marta Ruiz-Ortega; Jesus Egido; Alberto Ortiz
Journal:  Mediators Inflamm       Date:  2010-10-04       Impact factor: 4.711

Review 6.  Interleukin-21 is a T-helper cytokine that regulates humoral immunity and cell-mediated anti-tumour responses.

Authors:  Pallavur V Sivakumar; Donald C Foster; Christopher H Clegg
Journal:  Immunology       Date:  2004-06       Impact factor: 7.397

Review 7.  The TWEAK-Fn14 cytokine-receptor axis: discovery, biology and therapeutic targeting.

Authors:  Jeffrey A Winkles
Journal:  Nat Rev Drug Discov       Date:  2008-05       Impact factor: 84.694

8.  CSBF/C10orf99, a novel potential cytokine, inhibits colon cancer cell growth through inducing G1 arrest.

Authors:  Wen Pan; Yingying Cheng; Heyu Zhang; Baocai Liu; Xiaoning Mo; Ting Li; Lin Li; Xiaojing Cheng; Lianhai Zhang; Jiafu Ji; Pingzhang Wang; Wenling Han
Journal:  Sci Rep       Date:  2014-10-29       Impact factor: 4.379

9.  Tumor necrosis factor superfamily ligand mRNA expression profiles differ between humans and mice during homeostasis and between various murine kidney injuries.

Authors:  Satish Kumar Devarapu; Julia Felicitas Grill; Junhui Xie; Marc Weidenbusch; Mohsen Honarpisheh; Volker Vielhauer; Hans-Joachim Anders; Shrikant R Mulay
Journal:  J Biomed Sci       Date:  2017-09-19       Impact factor: 8.410

10.  TgROP18 targets IL20RB for host-defense-related-STAT3 activation during Toxoplasma gondii infection.

Authors:  Ling Kong; Dan Jiang; Cheng He; Jing Xia; Haixia Wei; Lijuan Zhou; Hongjuan Peng
Journal:  Parasit Vectors       Date:  2020-08-07       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.